http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007123900-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5d39fe4cef4ee47ad3c01dcaee17855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5ce453d31c1da40a11f093cb801c36
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-136
filingDate 2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c77463f6d9d3352916cd7c4f2dca87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ee853d957f60253ebec2eafb5e9c0e
publicationDate 2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007123900-A3
titleOfInvention Enantiomers of n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine borane as intermediates in the synthesis of duloxetine
abstract Duloxetine intermediates of formulae (I) and (II), processes for their preparation, and their conversion to pharmaceutically acceptable salts of duloxetine are described.
priorityDate 2006-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070720-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5362886-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226833421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9818212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24885299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454474681

Total number of triples: 25.